{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:19:48Z","timestamp":1792009188944,"version":"4.4.0"},"reference-count":35,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pain Manage."],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.2217\/pmt.13.35","type":"journal-article","created":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T12:00:51Z","timestamp":1378382451000},"page":"359-367","source":"Crossref","is-referenced-by-count":13,"title":["Pregabalin for the Management of Neuropathic Pain in Spinal Cord Injury"],"prefix":"10.1080","volume":"3","author":[{"given":"Kevin L","family":"Dalal","sequence":"first","affiliation":[{"name":"Department of Rehabilitation Medicine, University of Miami Miller School of Medicine, Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth R","family":"Felix","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, University of Miami Miller School of Medicine, Miami, FL, USA"},{"name":"Research Service, Department of Veterans Affairs Medical Center, Miami VA Healthcare System, Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana D","family":"Cardenas","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, University of Miami Miller School of Medicine, Miami, FL, USA"},{"name":"Research Service, Department of Veterans Affairs Medical Center, Miami VA Healthcare System, Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2013,9,5]]},"reference":[{"key":"e_1_3_2_3_1_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70059-4"},{"key":"e_1_3_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2010.02.024"},{"issue":"9","key":"e_1_3_2_3_3_1","first-page":"851","volume":"64","author":"Tzellos TG","year":"2008","unstructured":"Tzellos TG , PapazisisG, AmanitiE, KouvelasD. Efficacy of pregabalin and gabapentin for neuropathic pain in spinal cord injury: an evidence-based evaluation of the literature. Eur. J. Pharmacol.64(9) , 851\u2013858 (2008).","journal-title":"Eur. J. Pharmacol."},{"key":"e_1_3_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3076"},{"key":"e_1_3_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4056"},{"key":"e_1_3_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G078"},{"key":"e_1_3_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0801"},{"key":"e_1_3_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.2147\/nedt.S32237"},{"key":"e_1_3_2_3_9_1","first-page":"2033","article-title":"Pregabalin multiple-dose pharmacokinetics and safety\/tolerance in healthy volunteers.","volume":"1","author":"Busch J","year":"1999","unstructured":"Busch J , StrandJ, PosvarE et al. Pregabalin multiple-dose pharmacokinetics and safety\/tolerance in healthy volunteers. Pharm. Sci. 1 , 2033 (1999).","journal-title":"Pharm. Sci."},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2012.07.022"},{"key":"e_1_3_2_3_11_1","first-page":"971","article-title":"Pregabalin reduces posterior insula combined glutamage and glutamine in fibromyalgia (abstract).","volume":"63","author":"Harris RE","year":"2011","unstructured":"Harris RE , HugginsJP, PauerL et al. Pregabalin reduces posterior insula combined glutamage and glutamine in fibromyalgia (abstract). Arthritis Rheum. 63(Suppl. 10) , 971 (2011).","journal-title":"Arthritis Rheum."},{"key":"e_1_3_2_3_12_1","first-page":"2080","article-title":"Regional differences in the colonic absorption of pregabalin.","volume":"2","author":"Bockbrader HN","year":"2000","unstructured":"Bockbrader HN , RadulovicLL, StrandJC et al. Regional differences in the colonic absorption of pregabalin. Pharm Sci. 2 , 2080 (2000).","journal-title":"Pharm Sci."},{"key":"e_1_3_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.2165\/11536200-000000000-00000"},{"key":"e_1_3_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270009352087"},{"key":"e_1_3_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270003251119"},{"key":"e_1_3_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000244422.45278.ff"},{"key":"e_1_3_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318281546b"},{"key":"e_1_3_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2007.06.033"},{"key":"e_1_3_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.2147\/ndt.s1715"},{"key":"e_1_3_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/sc.2012.97"},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2012.02.031"},{"issue":"144","key":"e_1_3_2_3_22_1","first-page":"43633","volume":"70","year":"2005","unstructured":"Drug Enforcement Administration, Department of Justice. Schedules of controlled substances: placement of pregabalin into schedule V. Final rule. Fed. Register70(144) , 43633\u201343635 (2005).","journal-title":"Fed. Register"},{"key":"e_1_3_2_3_23_1","first-page":"CD007076","volume":"3","author":"Moore RA","year":"2009","unstructured":"Moore RA , StraubeS, WiffenPJ, DerryS, McQuayHJ. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst. Rev.3 , CD007076 (2009).","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_3_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03261976"},{"key":"e_1_3_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-2105"},{"key":"e_1_3_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2012.684044"},{"key":"e_1_3_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2006.11.006"},{"key":"e_1_3_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0b013e3282fb7629"},{"key":"e_1_3_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2008.03196.x"},{"key":"e_1_3_2_3_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2005.19204.x"},{"key":"e_1_3_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.166074"},{"key":"e_1_3_2_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2011.05.029"},{"key":"e_1_3_2_3_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1734-1140(12)70867-8"},{"key":"e_1_3_2_4_2_1","unstructured":"FDA approves Lyrica \u00ae for the management of neuropathic pain associated with spinal cord injury based on priority review. http:\/\/press.pfizer.com\/press-release\/fda-approves-lyrica-management-neuropathic-pain-associated-spinal-cord-injury-based-pr"},{"key":"e_1_3_2_4_3_1","unstructured":"Lyrica US physician prescribing information. http:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=561"}],"container-title":["Pain Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/pmt.13.35","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T19:16:23Z","timestamp":1715973383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/pmt.13.35"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.2217\/pmt.13.35"],"URL":"https:\/\/doi.org\/10.2217\/pmt.13.35","relation":{},"ISSN":["1758-1869","1758-1877"],"issn-type":[{"value":"1758-1869","type":"print"},{"value":"1758-1877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}